In vitro growth rates of cells harboring resistance mutations [8].

The table displays the type of resistance mutation (ordered in terms of decreasing growth rate), net growth rate (mean and standard error), and sensitivity to the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib. p210 refers to the drug-sensitive BCR-ABL-positive cell type.

本表格呈现了耐药突变类型（按生长速率降序排列）、净生长率（均值与标准误），以及对酪氨酸激酶抑制剂(tyrosine kinase inhibitors)伊马替尼(imatinib)、达沙替尼(dasatinib)及尼洛替尼(nilotinib)的敏感性。其中p210指代药物敏感性BCR-ABL阳性细胞类型。